ABBOTINDIA25,230.00

Abbott India Ltd.

· Pharma & Health
₹ CrorePeersPFIZERGLAXOIPCALABAJANTPHARMANTHEMMEDANTAGLENMARKBIOCON
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation71.271.830.0
+ Finance Costs12.511.429.0
+ Interest Income-224.0-258.1-258.2
+ Unrealised FX (Gain) / Loss-1.2
Changes in Working Capital
+ Inventories29.3-262.5-65.2
+ Trade Receivables — Current-1.7-63.215.7
+ Trade Payables — Current96.040.531.8
Cash from Operating Activities
Profit Before Tax (per I/S)1,617.81,887.02,079.3
Cash from Operations (pre-tax)1,617.31,458.91,858.9
+ Income Taxes Paid404.5447.1539.7
Cash from Operating Activities1,212.81,011.81,319.2
Cash from Investing Activities
+ Disp of Fixed Assets0.20.528.6
+ Interest Received — Investing143.6125.4384.5
Cash from Investing Activities-416.0182.2-371.4
Cash from Financing Activities
+ Payment of Lease Liabilities53.946.938.6
+ Interest Paid0.1
+ Dividends Paid1,009.3
Cash from Financing Activities-744.7-925.2-1,066.1
Net Changes in Cash52.1268.9-118.3
Closing Cash291.7560.6442.3
Reference Items
EBITDA1,453.11,694.61,892.1
EBITDA Margin %24.8426.4427.31
Free Cash Flow (CFO − Capex)1,212.81,011.81,319.2
Cash Flow to Net Income1.010.720.85
Cash Paid for Taxes404.5447.1539.7
Cash Paid for Interest0.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.